Rice Hall James & Associates LLC reduced its stake in Xylem Inc. (NYSE:XYL) by 39.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 61,714 shares of the company’s stock after selling 40,260 shares during the period. Rice Hall James & Associates LLC’s holdings in Xylem were worth $2,756,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. NN Investment Partners Holdings N.V. purchased a new position in shares of Xylem during the first quarter valued at approximately $31,109,000. JPMorgan Chase & Co. boosted its position in shares of Xylem by 38.4% in the first quarter. JPMorgan Chase & Co. now owns 485,227 shares of the company’s stock valued at $19,846,000 after buying an additional 134,589 shares during the period. BlackRock Japan Co. Ltd boosted its position in shares of Xylem by 19.4% in the first quarter. BlackRock Japan Co. Ltd now owns 257,505 shares of the company’s stock valued at $10,532,000 after buying an additional 41,804 shares during the period. BlackRock Institutional Trust Company N.A. boosted its position in shares of Xylem by 8.6% in the first quarter. BlackRock Institutional Trust Company N.A. now owns 5,296,799 shares of the company’s stock valued at $216,639,000 after buying an additional 417,259 shares during the period. Finally, BlackRock Group LTD boosted its position in shares of Xylem by 1.2% in the first quarter. BlackRock Group LTD now owns 1,799,568 shares of the company’s stock valued at $73,602,000 after buying an additional 20,700 shares during the period. 84.70% of the stock is owned by hedge funds and other institutional investors.
Shares of Xylem Inc. (NYSE:XYL) traded down 0.23% during mid-day trading on Thursday, reaching $51.83. The company had a trading volume of 993,717 shares. The firm’s 50-day moving average price is $50.98 and its 200 day moving average price is $46.02. The company has a market cap of $9.29 billion, a price-to-earnings ratio of 27.67 and a beta of 1.15. Xylem Inc. has a 52-week low of $31.67 and a 52-week high of $53.25.
Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $0.48 earnings per share for the quarter, topping the consensus estimate of $0.47 by $0.01. Xylem had a return on equity of 16.41% and a net margin of 9.22%. The business earned $932 million during the quarter, compared to the consensus estimate of $927.69 million. During the same period in the prior year, the company earned $0.43 EPS. Xylem’s revenue for the quarter was up 1.3% on a year-over-year basis. Equities analysts expect that Xylem Inc. will post $2.04 EPS for the current year.
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, September 21st. Investors of record on Wednesday, August 31st were given a dividend of $0.1549 per share. The ex-dividend date of this dividend was Monday, August 29th. This represents a $0.62 annualized dividend and a dividend yield of 1.20%. Xylem’s dividend payout ratio is currently 33.16%.
Several brokerages recently commented on XYL. Atlantic Securities raised Xylem from a “neutral” rating to an “overweight” rating and set a $54.00 target price for the company in a research report on Monday, August 22nd. RBC Capital Markets set a $51.00 price objective on Xylem and gave the company a “buy” rating in a report on Tuesday, August 16th. Royal Bank Of Canada lifted their price objective on Xylem from $47.00 to $51.00 and gave the company an “outperform” rating in a report on Tuesday, August 16th. Canaccord Genuity reissued a “hold” rating and set a $50.00 price objective (up from $45.00) on shares of Xylem in a report on Tuesday, August 16th. Finally, Barclays PLC lifted their price objective on Xylem from $39.00 to $45.00 and gave the company an “equal weight” rating in a report on Monday, July 18th. Nine equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $45.00.
In related news, insider Colin R. Sabol sold 27,473 shares of the company’s stock in a transaction on Thursday, September 8th. The stock was sold at an average price of $50.91, for a total transaction of $1,398,650.43. Following the completion of the sale, the insider now directly owns 65,530 shares in the company, valued at approximately $3,336,132.30. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Tomas Brannemo sold 8,524 shares of the company’s stock in a transaction on Wednesday, August 17th. The stock was sold at an average price of $50.06, for a total value of $426,711.44. The disclosure for this sale can be found here. Corporate insiders own 0.77% of the company’s stock.
Xylem Company Profile
Xylem Inc is engaged in the design, manufacturing, and application of engineered technologies for the water industry. The Company is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment.
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL).
Receive News & Ratings for Xylem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.